Navigating startups from concept to market is a formidable challenge. Early-stage investors make a difference by guiding MedTech innovators to startup success. The Key Tech team recently met with Dr. Deborah Hemingway, Managing Partner at investment firm Ecphora Capital. Dr. Hemingway shared her perspective on Maryland’s...
Key Tech client CoolStat was recently featured in the June issue of MedTech Strategist. Read the full article here. ...
Abbie Shoemaker recently attended the 2020 Bioelectronic Medicine Forum online. One of the key takeaways from the webinar was how the Covid-19 outbreak has spurred bioelectronic medicine companies to quickly pivot from doctor's office administered therapy devices into home-use devices where users are empowered to...
Managing technical and schedule risk is one of the toughest challenges during development of a complex medical device. Historically, the predictability of these programs has been set back by the “surprise” result of an empirical test after much of the design work is completed. The...
How do you design a fluidics system that can accurately dispense a wide variety of liquid ingredients ranging in dose-volume from fractions of a milliliter to multiple liters in an efficient way with the same pumping modality? This was the tough development challenge B. Braun...
As we wrap up our 4th blog post and head toward AACC2019 in Anaheim, CA we have a few more thoughts to share with you regarding “smarter healthcare”. We are looking forward to continuing the conversation at the meeting so please reach out to us...
It’s thrilling to bring new materials and technologies to life in products that have a real impact. We’re creating new devices across the continua of discovery and development, diagnostics, drug delivery, and monitoring. And we are leveraging sophisticated data tools to make the devices themselves...
Once, the earth was flat…and disease was defined by the organ in which it was thought to originate…and (lest we forget)…cancer cells did not circulate. Only some of this is ancient history. A few weeks ago over coffee, Caroline Popper (Popper & Co) and I had a...
A few weeks ago over coffee, Caroline Popper (Popper & Co) and I had a fascinating conversation about the path toward "Smarter Healthcare". This post is the first in a series of four that arise from that conversation and are informed by our careers working...
(Take-aways from: Precision Medicine World Conference 2019, Molecular Med Tri-Con 2019, and MedExec Women) The Precision Medicine industry is rocketing along with tremendous scientific advances and dynamic business models, representing the promise of better healthcare at lower cost. Key Tech works heavily across this industry, and...